Press release
India Vaccine Market Forecast to Hit INR 300.32B by 2035
The India vaccine market is experiencing significant growth due to the country's large population, high prevalence of infectious diseases, and increasing focus on local vaccine production and immunization programs. Valued at INR 129.21 Billion in 2025, the market is projected to grow at a CAGR of 8.80% during 2026-2035, reaching INR 300.32 Billion by 2035.
Vaccines are critical in preventing infectious diseases such as COVID-19, influenza, typhoid, hepatitis, HPV, and pneumococcal infections, among others. India's robust vaccine production capabilities, supported by leading manufacturers like Serum Institute of India, Bharat Biotech, and Panacea Biotec, have positioned the country as a key global player in vaccine development and distribution.
Market Overview and Current Landscape
Vaccines play a pivotal role in controlling infectious diseases and improving public health. India has one of the largest immunization programs in the world, including routine childhood vaccination as well as mass vaccination campaigns against emerging infectious diseases such as COVID-19.
Key Market Highlights
Market Value (2025): INR 129.21 Billion
Forecast Value (2035): INR 300.32 Billion
CAGR (2026-2035): 8.80%
Primary Drivers:
High prevalence of infectious diseases
Government initiatives promoting vaccination
Strategic collaborations and public-private partnerships
Growth in local manufacturing capabilities and vaccine R&D
Get a Free Sample Report with Table of Contents - https://www.expertmarketresearch.com/reports/indian-vaccine-market/requestsample.
Factors Driving Market Growth
High Burden of Infectious Diseases
India faces a significant burden of COVID-19, influenza, hepatitis, typhoid, rabies, and pneumococcal infections.
Vaccination programs are critical in reducing morbidity, mortality, and disease-related healthcare costs.
Government Initiatives and Public Health Programs
National Immunization Program (NIP) and other state-level vaccination campaigns expand coverage.
Policies promoting affordable vaccines, local production, and supply chain optimization drive market growth.
Rising Strategic Collaborations
Partnerships between domestic and international companies accelerate vaccine research, development, and distribution.
Technology transfers and joint ventures enhance production of advanced vaccines, including mRNA and recombinant vaccines.
Technological Advancements in Vaccine Development
mRNA vaccines have emerged as a promising platform for COVID-19 and other infectious diseases.
Live attenuated, inactivated, and subunit vaccines continue to dominate routine immunization programs.
Novel multivalent vaccines targeting multiple pathogens are being developed to improve efficiency.
Increasing Awareness and Acceptance
Growing awareness about vaccine-preventable diseases among adults and parents of children
Educational campaigns addressing vaccine hesitancy
Expansion of vaccination coverage beyond pediatric populations to adult and geriatric patients
Challenges Limiting Market Growth
Despite strong growth potential, the market faces challenges:
High Cost of Advanced Vaccines
mRNA and recombinant vaccines are costlier than traditional vaccines
Price sensitivity in rural populations may limit uptake
Cold Chain and Logistics Constraints
Vaccines require stringent temperature-controlled storage and transportation
Maintaining the cold chain across India's diverse geography is challenging
Regulatory Hurdles
Approvals from CDSCO (Central Drugs Standard Control Organization) and other regulatory bodies can affect time-to-market
Compliance with safety, efficacy, and manufacturing standards is mandatory
Vaccine Hesitancy and Misinformation
Misconceptions about vaccine safety and side effects may reduce uptake
Public education campaigns are essential to overcome hesitancy
Market Segmentation by Disease Type
India's vaccine market covers a wide range of infectious diseases:
COVID-19: Rapid deployment during the pandemic accelerated market growth
Influenza: Seasonal flu vaccination programs for high-risk populations
Typhoid: Pediatric and adult immunization in endemic areas
Hepatitis B & A: Routine immunization and preventive programs
HPV: Targeting cervical cancer prevention
DPT: Diphtheria, pertussis, and tetanus vaccines for children
Rabies: Post-exposure prophylaxis and routine prevention
Pneumococcal: Protects against pneumonia and invasive bacterial infections
MMR: Measles, mumps, and rubella vaccination for children
Polio: Routine immunization and eradication campaigns
Others: Emerging infectious diseases and region-specific vaccines
Read the Full Report with the Table of Contents - https://www.expertmarketresearch.com/reports/indian-vaccine-market.
Market Segmentation by Technology
Acellular or Subunit Vaccines
Contain purified antigenic components of pathogens
Safe for immunocompromised individuals and children
Inactivated Vaccines
Contain killed pathogens that cannot replicate
Widely used for influenza, polio, and hepatitis vaccines
Live Attenuated Vaccines
Contain weakened pathogens capable of inducing immunity
Examples include MMR, rotavirus, and varicella vaccines
mRNA Vaccines
Utilize messenger RNA to produce pathogen-specific proteins in the body
Gained prominence during the COVID-19 pandemic
Others
Recombinant, conjugate, and viral vector vaccines
Targeted toward emerging infectious diseases and specialized populations
Market Segmentation by Vaccine Type
Monovalent Vaccines: Target a single pathogen (e.g., hepatitis B, polio)
Multivalent Vaccines: Protect against multiple pathogens in a single dose (e.g., MMR, DPT combination vaccines)
Market Segmentation by Patient Type
Pediatric: Includes routine immunization and school-based vaccination programs
Adult: Influenza, hepatitis B, COVID-19, and booster vaccinations
Geriatric: Influenza, pneumococcal, and shingles vaccines targeting elderly populations
Market Segmentation by Route of Administration
Injectable: Intramuscular and subcutaneous vaccines, most widely used
Oral: Polio and rotavirus vaccines
Nasal: FluMist and emerging intranasal vaccines
Market Segmentation by End User
Hospitals: Primary centers for vaccine administration and mass immunization
Specialty Centres and Community Hospitals: Focus on preventive care and high-risk populations
Clinics: Outpatient immunization and vaccination campaigns
Others: Public health programs, NGOs, and mobile vaccination units
Regional Insights Within India
Urban Centers: Higher awareness, adoption, and access to advanced vaccines (mRNA, multivalent vaccines)
Rural Areas: Expanding coverage through government immunization programs and mobile units
Tier 2 and Tier 3 Cities: Growing vaccine demand due to rising healthcare awareness and local manufacturing initiatives
Competitive Landscape
India's vaccine market is characterized by strong domestic manufacturers and collaborations with global pharmaceutical companies. Leading players are investing in R&D, capacity expansion, and technology transfer.
Key Companies
GlaxoSmithKline Plc
Sanofi
Pfizer, Inc.
Merck & Co. Inc.
Serum Institute of India Pvt. Ltd.
Bharat Biotech International Ltd
Panacea Biotec
Cadila Pharmaceuticals Ltd.
Human Biological Institute
Haffkine Bio-Pharmaceutical Corporation Ltd
Strategies Adopted by Market Players
Strategic partnerships and collaborations for vaccine development
Expansion of local manufacturing and production capabilities
Focus on R&D for advanced platforms like mRNA and recombinant vaccines
Participation in government immunization initiatives and public health campaigns
Enhancing cold chain and distribution networks for wider reach
Technological Trends in the India Vaccine Market
mRNA and DNA Vaccine Development
Rapid vaccine development for infectious diseases
Potential for personalized vaccines targeting regional pathogens
Multivalent Vaccines
Reduce number of doses and improve compliance
Simultaneous protection against multiple diseases
Advanced Delivery Systems
Injectable, oral, and intranasal formulations
Needle-free delivery systems for pediatric and geriatric populations
Digital Immunization Platforms
Vaccine tracking and monitoring
AI-based predictive modeling for outbreak response and vaccination campaigns
Local Manufacturing and Self-Reliance
Emphasis on "Make in India" initiative
Scaling production for domestic and export markets
Future Outlook
The India vaccine market is expected to experience robust growth due to:
Rising prevalence of infectious diseases and new viral outbreaks
Increasing investment in vaccine R&D and production facilities
Expansion of immunization coverage to adult and geriatric populations
Technological innovation in vaccine platforms and delivery methods
Strategic collaborations between Indian and global vaccine manufacturers
By 2035, the market is projected to reach INR 300.32 Billion, reflecting a CAGR of 8.80%, driven by advanced vaccine technologies, government initiatives, and growing healthcare awareness.
Access More Reports
Cystic Fibrosis Treatment Market - https://bit.ly/4px732g.
Diabetic Macular Edema Market - https://bit.ly/44yiHln.
Diabetic Neuropathy Market - https://bit.ly/3LZqfY5.
Cranial Implants Market - https://bit.ly/3XSH61i.India Vaccine Market
Media Contact
Company Name: Claight Corporation
Contact Person: Roshan Kumar, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
About Us
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analysis provides the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today's competitive market.
Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organization's future success by acquiring one of our Expert Market Research reports today.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release India Vaccine Market Forecast to Hit INR 300.32B by 2035 here
News-ID: 4313160 • Views: …
More Releases from Expert Market Research
Cell and Gene Therapy Market Projected to Grow to USD 172B by 2035
What is driving the growth of the global cell and gene therapy market, and how is it expected to evolve by 2035?
The global cell and gene therapy market is witnessing rapid expansion due to increasing clinical trials, robust regulatory support, and breakthroughs in biotechnology. Valued at USD 21.43 Billion in 2025, the market is expected to grow at a CAGR of 23.17% from 2026 to 2035, reaching USD 172.22 Billion…
Global CDMO Market Forecast to Hit USD 588B by 2035
What is driving the growth of the global CDMO market, and how is it expected to evolve by 2035?
The global contract development and manufacturing organization (CDMO) market is experiencing significant growth, driven by rising demand for novel drugs, biologics, and therapies to address chronic diseases worldwide. The market was valued at USD 246.11 Billion in 2025 and is projected to grow at a CAGR of 9.10% between 2026 and 2035,…
Schizophrenia Market to Reach USD 14.46B by 2035 at 5.8% CAGR
What is driving the growth of the global schizophrenia market, and how is it expected to evolve by 2035?
The global schizophrenia market is experiencing steady growth as awareness, diagnosis, and treatment of schizophrenia increase worldwide. In 2025, the market attained a value of USD 8.23 Billion, and it is projected to grow at a CAGR of 5.80% between 2026 and 2035, reaching USD 14.46 Billion by 2035.
Schizophrenia, a chronic and…
Saudi Arabia Medical Gases Market to Grow at 7.10% CAGR by 2035
What is driving the growth of the Saudi Arabia medical gases market, and what trends are shaping its future?
The Saudi Arabia medical gases market is witnessing steady growth due to the expansion of the healthcare sector, increasing adoption of advanced medical technologies, and rising demand for hospital-based and home healthcare solutions. Valued at USD 155.08 Million in 2025, the market is projected to grow at a CAGR of 7.10%, reaching…
More Releases for Vaccine
Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
AstraZeneca
Bharat Biotech
Dynavax Technologies Corporation
GlaxoSmithKline
Johnson & Johnson
Merck and Co
Novartis
Pfizer
Sanofi Pasteur
Serum Institute of India
The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing…
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market…
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market.
Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top…
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze…
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Measles Vaccine Market Production and Demand Analysis 2019 to 2025
Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025
Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025
Measles Vaccine Market to Insight By 2025: Top Key Vendors
The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the…
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016.
Paediatric vaccine market is a billion dollar market accounting for a substantial proportion…
